Histologic and Combined Histologic and Endoscopic Outcomes After Guselkumab Maintenance Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Week 44 Results From the Phase 3 QUASAR Maintenance Study

被引：0

作者：

Panes, Julian ^{[1
]}

Dignass, Axel ^{[2
]}

Hisamatsu, Tadakazu ^{[3
]}

Yarandi, Shadi ^{[4
]}

Huang, Kuan-Hsiang G. ^{[5
]}

Germinaro, Matthew ^{[5
]}

Sridhar, Sunandini ^{[4
]}

Branigan, Patrick ^{[4
]}

Wilson, Rebbecca ^{[4
]}

Zhang, Hongyan ^{[5
]}

Magro, Fernando ^{[6
]}

Jairath, Vipul ^{[7
]}

Feagan, Brian G. ^{[7
]}

Lichtenstein, Gary R. ^{[8
]}

Rubin, David T. ^{[9
]}

Sands, Bruce E. ^{[10
]}

机构：

[1] CIBERehd, Hosp Clin Barcelona, IDIBAPS, Barcelona, Catalonia, Spain

[2] Goethe Univ, Agaples Markus Hosp, Frankfurt, Hessen, Germany

[3] Kyorin Univ, Sch Med, Tokyo, Japan

[4] Janssen Res & Dev LLC, Spring House, PA USA

[5] Janssen Res & Dev, Spring House, PA USA

[6] Univ Porto, Ctr Hospitalar, Porto, Portugal

[7] Western Univ, London, ON, Canada

[8] Univ Penn, Perelman Ctr Adv Med, Philadelphia, PA 19104 USA

[9] Univ Chicago Med, Inflammatory Bowel Dis, Chicago, IL USA

[10] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期

关键词：

D O I：

10.14309/01.ajg.0001035156.82149.4f

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

S1447

引用

页码：S1041 / S1041

页数：1

共 50 条

[1] Impact of Guselkumab Therapy on Histologic and Combined Histologic and Endoscopic Outcomes in Patients With Moderately to Severely Active Ulcerative Colitis: Week 12 Results From the Phase 3 QUASAR Induction Study
Panes, Julian
Sands, Bruce E.
Peyrin-Biroulet, Laurent
Yarandi, Shadi
Huang, Kuan-Hsiang G.
Germinaro, Matthew
Sridhar, Sunandini
Branigan, Patrick
Miao, Ye
Zhang, Hongyan
Hebuterne, Xavier
Gyokeres, Tibor
Hirai, Fumihito
Hisamatsu, Tadakazu
Rubin, David T.
Feagan, Brian G.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S874 - S875
[2] THE EFFICACY AND SAFETY OF GUSELKUMAB AS MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 QUASAR MAINTENANCE STUDY
Rubin, David T.
Allegretti, Jessica R.
Panes, Julian
Shipitofsky, Nicole
Yarandi, Shadi
Huang, Kuan-Hsiang G.
Germinaro, Matthew
Wilson, Rebbecca
Zhang, Hongyan
Feagan, Brian G.
Hisamatsu, Tadakazu
Lichtenstein, Gary R.
Bressler, Brian
Peyrin-Biroulet, Laurent
Sands, Bruce E.
Dignass, Axel
GASTROENTEROLOGY, 2024, 166 (05) : S180 - S180
[3] The Efficacy of Maintenance Treatment with Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 QUASAR Maintenance Study Results at Week 44 by Biologic/Janus Kinase History
Allegretti, Jessica R.
Panes, Julian
Peyrin-Biroulet, Laurent
Sands, Bruce E.
Yarandi, Shadi
Huang, Kuan-Hsiang G.
Germinaro, Matthew
Zhan, Jia
Zhang, Hongyan
Begun, Jakob
Kierkus, Jaroslaw
Kravchenko, Tetiana
Hisamatsu, Tadakazu
Rubin, David T.
Bressler, Brian
Dignass, Axel
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S882 - S882
[4] Corticosteroid Sparing Effects of Treatment With Guselkumab in Patients With Moderate to Severely Active Ulcerative Colitis: Phase 3 QUASAR Maintenance Study Results Through Week 44
Bressler, Brian
Allegretti, Jessica R.
Rubin, David T.
Shipitofsky, Nicole
Huang, Kuan-Hsiang G.
Germinaro, Matthew
Wilson, Rebbecca
Zhang, Hongyan
Armuzzi, Alessandro
Fishman, Sigal
Wang, Yufang
Panes, Julian
Lichtenstein, Gary R.
Peyrin-Biroulet, Laurent
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1002 - S1002
[5] Guselkumab maintenance treatment improves health-related quality of life in patients with moderately to severely active Ulcerative Colitis: Phase 3 QUASAR maintenance study
Bressler, B.
Peyrin-Biroulet, L.
Afif, W.
Samaan, M. A.
Wei, S. C.
Yarandi, S.
Germinaro, M.
Mistry, P.
Han, C.
Allegretti, J. R.
Lichtenstein, G. R.
JOURNAL OF CROHNS & COLITIS, 2025, 19 : i2133 - i2135
[6] P0636 Impact of obefazimod treatment on histologic and combined histologic and endoscopic outcomes in patients with moderately to severely active ulcerative colitis: results from the Phase 2b open-label maintenance study
Magro, F.
Peyrin-Biroulet, L.
Biedermann, L.
Sands, B. E.
Danese, S.
Dulai, P. S.
Dubinsky, M.
Tilg, H.
Siegmund, B.
Hisamatsu, T.
Shan, K.
Jacobstein, D.
Cataldi, F.
Rabbat, C.
Vermeire, S.
JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1251 - i1252
[7] THE EFFICACY AND SAFETY OF GUSELKUMAB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 QUASAR INDUCTION STUDY
Allegretti, Jessica R.
Peyrin-Biroulet, Laurent
Feagan, Brian G.
Bressler, Brian
Lichtenstein, Gary R.
Huang, Kuan-Hsiang G.
Germinaro, Matthew
Shipitofsky, Nicole
Jiang, Lingjing
Zhang, Hongyan
Hisamatsu, Tadakazu
Panes, Julian
Dignass, Axel
Sands, Bruce E.
Rubin, David T.
GASTROENTEROLOGY, 2023, 164 (06) : S1572 - S1572
[8] GUSELKUMAB IMPROVES SYMPTOMS OF FATIGUE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: PHASE 3 QUASAR INDUCTION STUDY RESULTS AT WEEK 12
Dignass, Axel
Panes, Julian
Rubin, David T.
Huang, Kuan-Hsiang G.
Germinaro, Matthew
Pandya, Dwiti
Han, Chenglong
Miao, Ye
Zhang, Hongyan
Gu, Fang
Rowbotham, David S.
Mihaly, Emese
Bressler, Brian
Lichtenstein, Gary R.
Allegretti, Jessica R.
GASTROENTEROLOGY, 2024, 166 (05) : S848 - S849
[9] Guselkumab improves symptoms of fatigue in patients with moderately to severely active Ulcerative Colitis: Phase 3 QUASAR induction study results at Week 12
Dignass, A.
Panes, J.
Rubin, D. T.
Huang, K. H. G.
Germinaro, M.
Pandya, D.
Han, C.
Miao, Y.
Zhang, H.
Gu, F.
Rowbotham, D.
Mihaly, E.
Bressler, B.
Lichtenstein, G. R.
Allegretti, J. R.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : I165 - I166
[10] THE EFFICACY AND SAFETY OF GUSELKUMAB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: PHASE 213 QUASAR STUDY RESULTS THROUGH WEEK 12
Allegretti, Jessica R.
Rubin, David T.
Bressler, Brian
Huang, Kuan-Hsiang G.
Shipitofsky, Nicole
Germinaro, Matthew
Zhang, Hongyan
Johanns, Jewel
Feagan, Brian
Sandborn, William J.
Sands, Bruce E.
Hisamatsu, Tadakazu
Lichi, Gary R.
Lichtenstein, Gary R.
Panes, Julian
Dignass, Axel
GASTROENTEROLOGY, 2022, 162 (07) : S963 - S964

← 1 2 3 4 5 →